Allarity

#药闻简讯# $Allarity(ALLR)$ 已获得 FDA 针对晚期卵巢癌治疗药物 Stenoparib 的快速通道指定资格
Stenoparib 是 Allarity 的领先项目，是一种口服的小分子双重靶向抑制剂，可抑制 PARP1/2 和端粒酶维持酶（Tankyrase 1 和 2）。目前，Tankyrase 作为癌症的新兴治疗靶点受到广泛关注，主要是...

$Allarity(ALLR)$ Allarity Therapeutics Says FDA Granted Fast-Track Designation to Stenoparib; Shares Rise Pre-Bell

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-019219  Act: 34  Size: 191 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-25-020081  Act: 34  Size: 195 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-064456  Act: 34  Size: 226 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-021482  Act: 34  Size: 188 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-060366  Act: 34  Size: 234 KB 网页链接

$Allarity(ALLR)$ 这个股票也是不知道该怎么操作了，干脆止损算了

$Allarity(ALLR)$ 8-K Current report, item 5.07 Accession Number: 0001437749-25-020652  Act: 34  Size: 173 KB 网页链接

$Allarity(ALLR)$ RW Registration Withdrawal Request Accession Number: 0001213900-25-056913  Act: NE  Size: 8 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-019471  Act: 34  Size: 192 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001213900-25-061639  Act: 34  Size: 363 KB 网页链接

$Allarity(ALLR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-25-027146  Act: 34  Size: 4 MB 网页链接

$Allarity(ALLR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-25-063558  Size: 2 KB 网页链接

$Allarity(ALLR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-080923  Act: 34  Size: 214 KB 网页链接

$Allarity(ALLR)$ 终于等到你，全部卖出不再留念

$Allarity(ALLR)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001213900-25-076643  Act: 34  Size: 20 KB 网页链接